India’s State Regulator To Hike Certification Fees, One By Five Times
This article was originally published in PharmAsia News
The Drug Control Administration of India's state of Hyderabad has raised the certification costs drug makers must pay for various steps in getting a product to market.
You may also be interested in...
Valneva is scaling up manufacture of its coronavirus vaccine alongside the clinical development program, with a view to meeting its commitment to provide millions of doses for use in the UK and the EU.
The UK government says it will begin a consultation on a future falsified medicines scheme for Great Britain within a year after the passage of new legislation on medicines and medical devices. Moves are also under way to ensure the smooth supply of medicines from GB to Cyprus, Ireland, Malta and Northern Ireland.
The sentences are the latest chapter in a long-running off-label marketing case.